Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Polymorphism in the Yersinia LcrV Antigen Enables Immune Escape From the Protection Conferred by an LcrV-Secreting Lactococcus Lactis in a Pseudotuberculosis Mouse Model.

Daniel C, Dewitte A, Poiret S, Marceau M, Simonet M, Marceau L, Descombes G, Boutillier D, Bennaceur N, Bontemps-Gallo S, Lemaître N, Sebbane F.

Front Immunol. 2019 Aug 2;10:1830. doi: 10.3389/fimmu.2019.01830. eCollection 2019.

2.

Nutrient depletion may trigger the Yersinia pestis OmpR-EnvZ regulatory system to promote flea-borne plague transmission.

Bontemps-Gallo S, Fernandez M, Dewitte A, Raphaël E, Gherardini FC, Elizabeth P, Koch L, Biot F, Reboul A, Sebbane F.

Mol Microbiol. 2019 Nov;112(5):1471-1482. doi: 10.1111/mmi.14372. Epub 2019 Sep 13.

PMID:
31424585
3.

To block or not to block: The adaptive manipulation of plague transmission.

Gandon S, Heitzmann L, Sebbane F.

Evol Lett. 2019 Mar 27;3(2):152-161. doi: 10.1002/evl3.111. eCollection 2019 Apr.

4.

Transcriptomic studies and assessment of Yersinia pestis reference genes in various conditions.

Koch L, Poyot T, Schnetterle M, Guillier S, Soulé E, Nolent F, Gorgé O, Neulat-Ripoll F, Valade E, Sebbane F, Biot F.

Sci Rep. 2019 Feb 21;9(1):2501. doi: 10.1038/s41598-019-39072-x.

5.

Plague: Bridging gaps towards better disease control.

D'Ortenzio E, Lemaître N, Brouat C, Loubet P, Sebbane F, Rajerison M, Baril L, Yazdanpanah Y.

Med Mal Infect. 2018 Aug;48(5):307-317. doi: 10.1016/j.medmal.2018.04.393. Epub 2018 Jun 1. Review.

PMID:
29773334
6.

Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.

Lemaître N, Liang X, Najeeb J, Lee CJ, Titecat M, Leteurtre E, Simonet M, Toone EJ, Zhou P, Sebbane F.

mBio. 2017 Jul 25;8(4). pii: e00674-17. doi: 10.1128/mBio.00674-17.

7.

Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.

Daniel C, Titecat M, Poiret S, Cayet D, Boutillier D, Simonet M, Sirard JC, Lemaître N, Sebbane F.

Vaccine. 2016 Nov 11;34(47):5762-5767. doi: 10.1016/j.vaccine.2016.09.060. Epub 2016 Oct 11.

PMID:
27742220
8.

High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitors.

Titecat M, Liang X, Lee CJ, Charlet A, Hocquet D, Lambert T, Pagès JM, Courcol R, Sebbane F, Toone EJ, Zhou P, Lemaitre N.

J Antimicrob Chemother. 2016 Oct;71(10):2874-82. doi: 10.1093/jac/dkw210. Epub 2016 Jun 20.

9.

Drug design from the cryptic inhibitor envelope.

Lee CJ, Liang X, Wu Q, Najeeb J, Zhao J, Gopalaswamy R, Titecat M, Sebbane F, Lemaitre N, Toone EJ, Zhou P.

Nat Commun. 2016 Feb 25;7:10638. doi: 10.1038/ncomms10638.

10.

Evaluation of the Role of the opgGH Operon in Yersinia pseudotuberculosis and Its Deletion during the Emergence of Yersinia pestis.

Quintard K, Dewitte A, Reboul A, Madec E, Bontemps-Gallo S, Dondeyne J, Marceau M, Simonet M, Lacroix JM, Sebbane F.

Infect Immun. 2015 Sep;83(9):3638-47. doi: 10.1128/IAI.00482-15. Epub 2015 Jul 6.

11.

Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells.

Goubard A, Loïez C, Abe J, Fichel C, Herwegh S, Faveeuw C, Porte R, Cayet D, Sebbane F, Penet S, Foligné B, Desreumaux P, Saito H, Sirard JC, Simonet M, Carnoy C.

Infect Immun. 2015 May;83(5):2053-64. doi: 10.1128/IAI.02339-14. Epub 2015 Mar 9.

12.

Functional and structural analysis of HicA3-HicB3, a novel toxin-antitoxin system of Yersinia pestis.

Bibi-Triki S, Li de la Sierra-Gallay I, Lazar N, Leroy A, Van Tilbeurgh H, Sebbane F, Pradel E.

J Bacteriol. 2014 Nov;196(21):3712-23. doi: 10.1128/JB.01932-14. Epub 2014 Aug 11.

13.

Yersinia pestis requires the 2-component regulatory system OmpR-EnvZ to resist innate immunity during the early and late stages of plague.

Reboul A, Lemaître N, Titecat M, Merchez M, Deloison G, Ricard I, Pradel E, Marceau M, Sebbane F.

J Infect Dis. 2014 Nov 1;210(9):1367-75. doi: 10.1093/infdis/jiu274. Epub 2014 May 9.

PMID:
24813471
14.

New insights into how Yersinia pestis adapts to its mammalian host during bubonic plague.

Pradel E, Lemaître N, Merchez M, Ricard I, Reboul A, Dewitte A, Sebbane F.

PLoS Pathog. 2014 Mar 27;10(3):e1004029. doi: 10.1371/journal.ppat.1004029. eCollection 2014 Mar.

15.

Inheritance of the lysozyme inhibitor Ivy was an important evolutionary step by Yersinia pestis to avoid the host innate immune response.

Derbise A, Pierre F, Merchez M, Pradel E, Laouami S, Ricard I, Sirard JC, Fritz J, Lemaître N, Akinbi H, Boneca IG, Sebbane F.

J Infect Dis. 2013 May 15;207(10):1535-43. doi: 10.1093/infdis/jit057. Epub 2013 Feb 12.

PMID:
23402825
16.

Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.

Lemaître N, Ricard I, Pradel E, Foligné B, Courcol R, Simonet M, Sebbane F.

PLoS One. 2012;7(12):e52503. doi: 10.1371/journal.pone.0052503. Epub 2012 Dec 20.

17.

Role of the Yersinia pestis yersiniabactin iron acquisition system in the incidence of flea-borne plague.

Sebbane F, Jarrett C, Gardner D, Long D, Hinnebusch BJ.

PLoS One. 2010 Dec 17;5(12):e14379. doi: 10.1371/journal.pone.0014379.

18.

TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa.

Van Maele L, Carnoy C, Cayet D, Songhet P, Dumoutier L, Ferrero I, Janot L, Erard F, Bertout J, Leger H, Sebbane F, Benecke A, Renauld JC, Hardt WD, Ryffel B, Sirard JC.

J Immunol. 2010 Jul 15;185(2):1177-85. doi: 10.4049/jimmunol.1000115. Epub 2010 Jun 21.

19.

Body lice, yersinia pestis orientalis, and black death.

Ayyadurai S, Sebbane F, Raoult D, Drancourt M.

Emerg Infect Dis. 2010 May;16(5):892-3. doi: 10.3201/eid1605.091280. No abstract available.

20.

Transit through the flea vector induces a pretransmission innate immunity resistance phenotype in Yersinia pestis.

Vadyvaloo V, Jarrett C, Sturdevant DE, Sebbane F, Hinnebusch BJ.

PLoS Pathog. 2010 Feb 26;6(2):e1000783. doi: 10.1371/journal.ppat.1000783.

21.

Autophagosomes can support Yersinia pseudotuberculosis replication in macrophages.

Moreau K, Lacas-Gervais S, Fujita N, Sebbane F, Yoshimori T, Simonet M, Lafont F.

Cell Microbiol. 2010 Aug;12(8):1108-23. doi: 10.1111/j.1462-5822.2010.01456.x. Epub 2010 Feb 23.

PMID:
20180800
22.

Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.

Daniel C, Sebbane F, Poiret S, Goudercourt D, Dewulf J, Mullet C, Simonet M, Pot B.

Vaccine. 2009 Feb 18;27(8):1141-4. doi: 10.1016/j.vaccine.2008.12.022. Epub 2009 Jan 9.

PMID:
19135495
23.

The Yersinia pestis caf1M1A1 fimbrial capsule operon promotes transmission by flea bite in a mouse model of bubonic plague.

Sebbane F, Jarrett C, Gardner D, Long D, Hinnebusch BJ.

Infect Immun. 2009 Mar;77(3):1222-9. doi: 10.1128/IAI.00950-08. Epub 2008 Dec 22.

24.

Analysis of Yersinia pestis gene expression in the flea vector.

Vadyvaloo V, Jarrett C, Sturdevant D, Sebbane F, Hinnebusch BJ.

Adv Exp Med Biol. 2007;603:192-200. Review.

PMID:
17966415
26.

Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague.

Sebbane F, Lemaître N, Sturdevant DE, Rebeil R, Virtaneva K, Porcella SF, Hinnebusch BJ.

Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11766-71. Epub 2006 Jul 24.

27.

Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague.

Sebbane F, Jarrett CO, Gardner D, Long D, Hinnebusch BJ.

Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5526-30. Epub 2006 Mar 27.

28.

Poor vector competence of fleas and the evolution of hypervirulence in Yersinia pestis.

Lorange EA, Race BL, Sebbane F, Hinnebusch BJ.

J Infect Dis. 2005 Jun 1;191(11):1907-12. Epub 2005 Apr 29.

PMID:
15871125
29.

Kinetics of disease progression and host response in a rat model of bubonic plague.

Sebbane F, Gardner D, Long D, Gowen BB, Hinnebusch BJ.

Am J Pathol. 2005 May;166(5):1427-39.

30.

The pmrF polymyxin-resistance operon of Yersinia pseudotuberculosis is upregulated by the PhoP-PhoQ two-component system but not by PmrA-PmrB, and is not required for virulence.

Marceau M, Sebbane F, Ewann F, Collyn F, Lindner B, Campos MA, Bengoechea JA, Simonet M.

Microbiology. 2004 Dec;150(Pt 12):3947-57.

PMID:
15583148
31.
32.

Flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague.

Jarrett CO, Sebbane F, Adamovicz JJ, Andrews GP, Hinnebusch BJ.

Infect Immun. 2004 Apr;72(4):2052-6.

33.

Function and regulation of the Salmonella-like pmrF antimicrobial peptide resistance operon in Yersinia pseudotuberculosis.

Marceau M, Sebbane F, Collyn F, Simonet M.

Adv Exp Med Biol. 2003;529:253-6. No abstract available.

PMID:
12756767
34.

Genes encoding specific nickel transport systems flank the chromosomal urease locus of pathogenic yersiniae.

Sebbane F, Mandrand-Berthelot MA, Simonet M.

J Bacteriol. 2002 Oct;184(20):5706-13.

35.
36.

The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis.

Carnoy C, Floquet S, Marceau M, Sebbane F, Haentjens-Herwegh S, Devalckenaere A, Simonet M.

J Bacteriol. 2002 Aug;184(16):4489-99.

37.

Silencing and reactivation of urease in Yersinia pestis is determined by one G residue at a specific position in the ureD gene.

Sebbane F, Devalckenaere A, Foulon J, Carniel E, Simonet M.

Infect Immun. 2001 Jan;69(1):170-6.

Supplemental Content

Loading ...
Support Center